Table 1. Sepsis animal model.
Pharmacological agents |
Animals used |
Challenges |
Results |
Ref. |
BN 5021 |
Mouse |
Intravenous LPS |
Positive |
[83] |
TAK-242 |
Mouse |
Intraperitoneal LPS |
Positive |
[84] |
Tifacogin |
Baboon |
Viable intravenous E. coli |
Positive |
[85] |
BB-882 |
Mouse |
Intravenous LPS |
Positive |
[86] |
Tifacogin |
Mouse |
Cecal ligation and puncture (CLP) |
Positive |
[87] |
IL1-RA |
Mouse |
Intraperitoneal LPS |
Positive |
[88] |
Methylprednisolone sodium succinate |
Baboon |
Viable intravenous E. coli |
Positive |
[89] |
Lenercept |
Baboon |
Viable intravenous E. coli |
Positive |
[90] |
Tifacogin |
Rabbit |
Peritonitis caused by E. coli 018: K+ |
Positive |
[91] |
CDP571 |
Baboon |
Viable intravenous E. coli |
Positive |
[92] |